Last reviewed · How we verify
Low-dose esketamine infusion
At a glance
| Generic name | Low-dose esketamine infusion |
|---|---|
| Sponsor | Anqing Municipal Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients Undergoing Major Abdominal Procedures - A Pilot Study (NA)
- The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression (PHASE4)
- The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery (NA)
- Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery (PHASE4)
- Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes (PHASE4)
- Analgesic Effects of Low-dose S-ketamine in Major Spine Fusion Surgery (PHASE4)
- Ketamine for Postherpetic Neuralgia With Depression (PHASE4)
- ESKetamine Low-dose vs Ketamine Low-dose for Severe Acute Pain in Emergency Units, Comparison of PsychodyslEptic Effects (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |